
Obesity Medical Education through Storytelling
How do you educate professionals about obesity care? I recently had the opportunity to participate in a panel discussion about obesity medication (semaglutide) for the treatment of high-risk patients with cardiovascular disease (SELECT trial) and its 2-year outcome results (STEP 5) at the Obesity Week and American Heart Association meetings. It was sponsored by Novo